Extreme Movers: Perplexity's picks for 2026-10-28
Perplexity picked VRT, WEN, ENPH, FFIV, AXGN for a 1-day horizon. Average directional return: +2.90%. Directions called correctly: 80%.
| Experiment | Extreme Movers |
|---|---|
| Model | Perplexity |
| Prompt version | extreme-movers-v11 |
| Asked | |
| Horizon | 1-day |
| Measured from | 2026-10-28 |
| Measured to | 2026-10-29 |
| Benchmark | SPY |
| Status | Settled |
| Average directional return | +2.90% |
| Directions called correctly | 80% |
| Benchmark return | -0.29% |
The picks
| Rank | Symbol | Direction | Price change | Return in the called direction | Confidence | vs benchmark | Called right |
|---|---|---|---|---|---|---|---|
| 1 | VRT | up | +3.70% | +3.70% | 68% | +3.99% | Yes |
| 2 | WEN | up | -0.37% | -0.37% | 62% | -0.08% | No |
| 3 | ENPH | down | -0.80% | +0.80% | 60% | +1.09% | Yes |
| 4 | FFIV | down | -3.61% | +3.61% | 58% | +3.91% | Yes |
| 5 | AXGN | up | +6.76% | +6.76% | 45% | +7.05% | Yes |
The model's market view
US equities are in an earnings-driven, high-dispersion session ahead of the Federal Reserve decision and Microsoft and Alphabet results. Substantive earnings surprises are dominating intraday moves: Vertiv and Wendy's are rising on company-specific positive news, while Enphase and F5 are falling on weak results or guidance. I favor continuation for moves backed by hard catalysts, with the main risk that extreme opening moves mean-revert later in the session.
Why each pick
VRT
Vertiv is the strongest substantive continuation candidate: it reported Q3 net sales of $4.31 billion versus roughly $3.76 billion consensus, adjusted EPS of $2.21 versus $1.82 expected, and raised full-year 2026 guidance. The move is earnings-driven rather than speculative, and the stock's large market cap and heavy session turnover support tradability. I used the live intraday quote of $238.81, up 14.50% in the source session; the 20-day average dollar volume could not be independently verified, so that field is omitted, although the session's multi-million-share volume indicates liquidity far above the $20 million threshold. Risk: a 14%-plus intraday gain can fade if the broader AI-infrastructure trade weakens into the Fed decision.
WEN
Wendy's surged after Trian Fund Management reportedly offered $7.35 per share in cash, valuing the company at about $1.4 billion. This is a substantive, company-specific takeover catalyst rather than a technical move, and the offer price sits above the intraday quote, giving the shares a visible anchor. I used the live intraday quote of $7.12, up 15.99% in the source session. Market cap was verified at about $1.34 billion and the price is above $5; the 20-day average dollar volume could not be independently verified, so that field is omitted, though intraday volume of more than 9 million shares implies dollar turnover near $65 million. Risk: deal uncertainty, regulatory or financing conditions, and a possible fade if investors doubt the offer will lead to a definitive agreement.
ENPH
Enphase is a substantive downside continuation candidate after reporting Q3 revenue of $293.3 million, down from $410.4 million a year earlier, alongside results and guidance that disappointed investors; premarket reports showed the shares down more than 15%. The negative catalyst is fundamental, and the stock remains above the $5 price floor with a verified market cap near $3.88 billion. I used the live intraday quote of $25.43, down 14.57% in the source session; the 20-day average dollar volume could not be independently verified and is omitted, although intraday volume above 9.5 million shares indicates very large dollar turnover. Risk: solar stocks are volatile and a deeply oversold name can bounce sharply once the initial earnings selling exhausts.
FFIV
F5 is a substantive downside continuation candidate: it beat fiscal Q4 expectations but issued a fiscal 2027 outlook that disappointed investors, and Piper Sandler downgraded the shares to Neutral. The move is guidance-driven rather than purely speculative. I used the live intraday quote of $389.84, down 15.13% in the source session; market cap was verified near $26.01 billion and the stock easily clears the price and market-cap floors. The 20-day average dollar volume could not be independently verified, so that field is omitted, but the company's size and normal trading activity indicate the $20 million threshold is very likely met. Risk: after a 15% decline, value buyers may attempt a reversal, particularly if the broader software complex stabilizes.
AXGN
Axogen is the fifth source-session extreme mover, trading near $45.68, up 21.95% intraday, with a market cap of about $2.20 billion, satisfying the price and market-cap floors. I could not verify a specific same-day company catalyst or the 20-day average dollar volume from the available sources, so the catalyst is treated as speculative and the dollar-volume field is omitted rather than guessed. The continuation thesis is therefore weaker and confidence is lower: a 22% intraday advance without a clearly confirmed fundamental catalyst is prone to intraday mean reversion. Risk: if the move is driven by a transient news item or short covering, the next-session close could readily reverse.
Other models on the same run
| Model | Picks | Average directional return | Directions called correctly |
|---|---|---|---|
| Muse Spark 1.1 | VRT, SOFI, AXGN, BA, FFIV | -1.30% | 40% |
| Grok 4.7 | HRI, KNSA, INOD, XYL, BA | +0.71% | 40% |
| GPT-5.1 | HRI, BA, XYL, KNSA, SOFI | +2.07% | 60% |
| DeepSeek | HRI, BA, XYL, KNSA, SOFI | +2.07% | 60% |
| GPT-6 | XYL, HRI, SOFI, KNSA, INOD | +3.39% | 80% |
| Claude Sonnet 5.5 | UCTT, ENPH, INTA, INOD, RAPP | -0.22% | 60% |
| Gemini 3.6 Flash High | VRT, ENPH, WEN, UCTT, BSX | +1.50% | 100% |
Written up on ForecastNest Insights: Extreme Movers: Perplexity's picks for 2026-10-28.
ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.